Literature DB >> 20211758

A second class of nuclear receptors for oxysterols: Regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol).

Yongjun Wang1, Naresh Kumar, Christine Crumbley, Patrick R Griffin, Thomas P Burris.   

Abstract

The retinoic acid receptor-related orphan receptors alpha and gamma (RORalpha [NR1F1] and RORgamma [NR1F3]) are members of the nuclear hormone receptor superfamily. These 2 receptors regulate many physiological processes including development, metabolism and immunity. We recently found that certain oxysterols, namely the 7-substituted oxysterols, bound to the ligand binding domains (LBDs) of RORalpha and RORgamma with high affinity, altered the LBD conformation and reduced coactivator binding resulting in suppression of the constitutive transcriptional activity of these two receptors. Here, we show that another oxysterol, 24S-hydroxycholesterol (24S-OHC), is also a high affinity ligand for RORalpha and RORgamma (K(i) approximately 25 nM). 24S-OHC is also known as cerebrosterol due to its high level in the brain where it plays an essential role as an intermediate in cholesterol elimination from the CNS. 24S-OHC functions as a RORalpha/gamma inverse agonist suppressing the constitutive transcriptional activity of these receptors in cotransfection assays. Additionally, 24S-OHC suppressed the expression of several RORalpha target genes including BMAL1 and REV-ERBalpha in a ROR-dependent manner. We also demonstrate that 24S-OHC decreases the ability of RORalpha to recruit the coactivator SRC-2 when bound to the BMAL1 promoter. We also noted that 24(S), 25-epoxycholesterol selectively suppressed the activity of RORgamma. These data indicate that RORalpha and RORgamma may serve as sensors of oxsterols. Thus, RORalpha and RORgamma display an overlapping ligand preference with another class of oxysterol nuclear receptors, the liver X receptors (LXRalpha [NR1H3] and LXRbeta [NR1H2]). Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20211758      PMCID: PMC2886165          DOI: 10.1016/j.bbalip.2010.02.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  34 in total

Review 1.  Nuclear hormone receptors in T lymphocytes.

Authors:  Astar Winoto; Dan R Littman
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

2.  Transcriptional regulation of human Rev-erbalpha gene expression by the orphan nuclear receptor retinoic acid-related orphan receptor alpha.

Authors:  Eric Raspè; Gisèle Mautino; Caroline Duval; Coralie Fontaine; Hélène Duez; Olivier Barbier; Didier Monte; Jamila Fruchart; Jean-Charles Fruchart; Bart Staels
Journal:  J Biol Chem       Date:  2002-10-10       Impact factor: 5.157

3.  X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha.

Authors:  Joerg A Kallen; Jean-Marc Schlaeppi; Francis Bitsch; Sabine Geisse; Martin Geiser; Isabelle Delhon; Brigitte Fournier
Journal:  Structure       Date:  2002-12       Impact factor: 5.006

4.  A functional genomics strategy reveals Rora as a component of the mammalian circadian clock.

Authors:  Trey K Sato; Satchidananda Panda; Loren J Miraglia; Teresa M Reyes; Radu D Rudic; Peter McNamara; Kinnery A Naik; Garret A FitzGerald; Steve A Kay; John B Hogenesch
Journal:  Neuron       Date:  2004-08-19       Impact factor: 17.173

5.  Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.

Authors:  Gloria Lena Vega; Myron F Weiner; Anne M Lipton; Klaus Von Bergmann; Dieter Lutjohann; Carol Moore; Doris Svetlik
Journal:  Arch Neurol       Date:  2003-04

6.  Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system.

Authors:  Karl D Whitney; Michael A Watson; Jon L Collins; William G Benson; Tammy M Stone; Mary Jo Numerick; Timothy K Tippin; Joan G Wilson; Deborah A Winegar; Steven A Kliewer
Journal:  Mol Endocrinol       Date:  2002-06

7.  24(S),25-Epoxycholesterol. Evidence consistent with a role in the regulation of hepatic cholesterogenesis.

Authors:  T A Spencer; A K Gayen; S Phirwa; J A Nelson; F R Taylor; A A Kandutsch; S K Erickson
Journal:  J Biol Chem       Date:  1985-11-05       Impact factor: 5.157

8.  Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter.

Authors:  Raphaël Métivier; Graziella Penot; Michael R Hübner; George Reid; Heike Brand; Martin Kos; Frank Gannon
Journal:  Cell       Date:  2003-12-12       Impact factor: 41.582

Review 9.  Alzheimer's disease: the cholesterol connection.

Authors:  Luigi Puglielli; Rudolph E Tanzi; Dora M Kovacs
Journal:  Nat Neurosci       Date:  2003-04       Impact factor: 24.884

10.  A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes.

Authors:  Yu Liang; Suizhen Lin; Thomas P Beyer; Youyan Zhang; Xin Wu; Kelly R Bales; Ronald B DeMattos; Patrick C May; Shuyu Dan Li; Xian-Cheng Jiang; Patrick I Eacho; Guoqing Cao; Steven M Paul
Journal:  J Neurochem       Date:  2004-02       Impact factor: 5.372

View more
  49 in total

Review 1.  Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity.

Authors:  Thomas P Burris; Scott A Busby; Patrick R Griffin
Journal:  Chem Biol       Date:  2012-01-27

2.  Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORα and RORγ.

Authors:  Yongjun Wang; Naresh Kumar; Philippe Nuhant; Michael D Cameron; Monica A Istrate; William R Roush; Patrick R Griffin; Thomas P Burris
Journal:  ACS Chem Biol       Date:  2010-11-19       Impact factor: 5.100

Review 3.  Endogenous ligands for nuclear receptors: digging deeper.

Authors:  Michael Schupp; Mitchell A Lazar
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

4.  Identification of SR3335 (ML-176): a synthetic RORα selective inverse agonist.

Authors:  Naresh Kumar; Douglas J Kojetin; Laura A Solt; K Ganesh Kumar; Philippe Nuhant; Derek R Duckett; Michael D Cameron; Andrew A Butler; William R Roush; Patrick R Griffin; Thomas P Burris
Journal:  ACS Chem Biol       Date:  2010-12-06       Impact factor: 5.100

5.  Structural basis of digoxin that antagonizes RORgamma t receptor activity and suppresses Th17 cell differentiation and interleukin (IL)-17 production.

Authors:  Saori Fujita-Sato; Shuichiro Ito; Takashi Isobe; Takao Ohyama; Kenji Wakabayashi; Kaoru Morishita; Osamu Ando; Fujio Isono
Journal:  J Biol Chem       Date:  2011-07-06       Impact factor: 5.157

6.  Small molecule amides as potent ROR-γ selective modulators.

Authors:  Pasha M Khan; Bahaa El-Dien M El-Gendy; Naresh Kumar; Ruben Garcia-Ordonez; Li Lin; Claudia H Ruiz; Michael D Cameron; Patrick R Griffin; Theodore M Kamenecka
Journal:  Bioorg Med Chem Lett       Date:  2012-11-22       Impact factor: 2.823

Review 7.  Steroid receptor coactivators: servants and masters for control of systems metabolism.

Authors:  Erin Stashi; Brian York; Bert W O'Malley
Journal:  Trends Endocrinol Metab       Date:  2014-06-19       Impact factor: 12.015

Review 8.  The obesity-related pathology and Th17 cells.

Authors:  Yusuke Endo; Koutaro Yokote; Toshinori Nakayama
Journal:  Cell Mol Life Sci       Date:  2016-10-18       Impact factor: 9.261

9.  Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiation.

Authors:  Pejman Soroosh; Jiejun Wu; Xiaohua Xue; Jiao Song; Steven W Sutton; Marciano Sablad; Jingxue Yu; Marina I Nelen; Xuejun Liu; Glenda Castro; Rosa Luna; Shelby Crawford; Homayon Banie; Rose A Dandridge; Xiaohu Deng; Anton Bittner; Chester Kuei; Mandana Tootoonchi; Natasha Rozenkrants; Krystal Herman; Jingjin Gao; Xia V Yang; Kacey Sachen; Karen Ngo; Wai-Ping Fung-Leung; Steven Nguyen; Aimee de Leon-Tabaldo; Jonathan Blevitt; Yan Zhang; Maxwell D Cummings; Tadimeti Rao; Neelakandha S Mani; Changlu Liu; Murray McKinnon; Marcos E Milla; Anne M Fourie; Siquan Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

Review 10.  REV-ERB and ROR nuclear receptors as drug targets.

Authors:  Douglas J Kojetin; Thomas P Burris
Journal:  Nat Rev Drug Discov       Date:  2014-03       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.